The outcomes of chemotherapy only treatment on mild spinal tuberculosis
© Zhang et al. 2016
Received: 8 October 2015
Accepted: 11 April 2016
Published: 14 May 2016
The treatments for spinal tuberculosis (TB) patients without absolute surgical indications have been controversial. Some people believed that most spinal TB patients were indicated for surgery, while other people believed in chemotherapy only. To help clarify the treatment over spinal TB patients without absolute surgical indications, we characterized a subtype spinal TB and then analyzed the treatment outcomes of standard chemotherapy alone.
In this retrospective study, 740 adult patients of spinal TB from January 2005 to January 2013 in our institution were reviewed. Patients who fit into the characterizations of mild spinal TB were started by standard chemotherapy for 18 months and followed up for at least 2 years upon the completion of treatment. The overall outcome, neurological function, local kyphosis, and level of pain at different time points were assessed.
After starting the conservative treatment, 89 out of 740 patients were chosen for chemotherapy alone, and all patients were followed up for at least 2 years (ranging from 24 to 50 months) upon the completion of the treatment. Of 89 patients, 95.4 % of patients showed a definite and clinical response within 1 month after starting the treatment, 69 % of patients had excellent to good results, with no complications of the disease, and 77.5 % had asymptomatic local kyphosis with intact neurological function; solid bony fusion of adjacent segment was achieved in 88.8 % of patients.
We believe that the mild spinal TB respond well to the standard chemotherapy, and the detailed description of mild TB would provide crucial guidance in determination of conservative treatment.
KeywordsMild spinal tuberculosis Standard chemotherapy alone Treatment outcome
The World Health Organization reports that China ranks second among the 22 countries with the highest burden of tuberculosis . Spinal tuberculosis (TB) is the most common form of extrapulmonary tuberculosis, accounting for approximately 1 to 3 % of all tuberculosis cases .
The management for spinal TB includes conservative and operative treatments. So far, the absolute surgical indications for spinal TB include (1) progressive neurologic deficit, (2) progressive increase in spinal deformity (coronal or sagittal) (3) failed conservative treatment including 1 and 2 above or severe pain due to abscess or spinal instability, and (4) uncertain diagnosis: this could be an inability to obtain microbiological diagnosis from microscopy, culture, or even via detection of mycobacterium DNA using polymerase chain reaction (PCR) techniques . Meanwhile, there is no agreement upon the indications of conservative treatment. Several classifications have been proposed to help with the determination, and most spinal TB patients were recommended for surgery accordingly. On the other hand, however, recent literatures questioned the efficacy of surgery in improving the outcomes of spinal TB .
Fundamentally, the treatment of tuberculosis is by chemotherapy and surgery attempts only to extirpate the complications arising from the disease process. Hence, most cases of spinal TB merit medical rather than surgical treatment, especially the mild spinal TB.
In the present study, we sought to clarify the indications of conservative treatment for spinal TB by analyzing the outcomes of mild spinal TB cases treated by nonoperative methods in our center.
A retrospective study was made of 740 consecutive adult patients with spinal TB who were diagnosed and treated in our center from January 2005 to January 2013. The diagnosis of spinal TB was made upon the medical history, clinical manifestations, radiology, lab tests, and histology samples if possible. Only patients who started conservative treatment when they were presented to our clinic were included in our study. The indications of conservative treatment included (1) mild to moderate neurologic deficit (no less than American Spinal Injury Association (ASIA) D), (2) single vertebral involvement with central lesion or multivertebral involvement (less than 3) with edge type lesion, (3) vertebral accessory tuberculosis without spinal canal involvement, (4) vertebral body collapse less than 1/3 of total height, (5) limited range of paravertebral abscess (within one level vertebrae, no retropharyngeal abscess, or psoas abscess), (6) no significant kyphosis (less than 30°), and (7) no significant intervertebral instability  (a sagittal plane displacement greater than 2.5 mm in the thoracic spine as demonstrated on lateral radiographs was considered potentially unstable, a sagittal plane displacement greater than 4.5 mm in the lumbar spine, or 15 % of the anteroposterior diameter of the vertebral body as demonstrated on a static lateral radiograph, was considered potentially unstable). The contraindications for conservative treatments included skeletal immaturity, pregnancy at the time of treatment, intracanal tumor or metastatic tumor, poor compliance to treatment due to mental conditions, and significantly impaired hepatic function (alanine aminotransferase, ALT and aspartate aminotransferase, AST higher than two times of normal level).
Patients who met all the above criteria were treated conservatively, and patients with deteriorating neurologic function (worse than ASIA D) or progressive kyphosis (greater than 40°) while on anti-tuberculosis chemotherapy were considered for surgical treatments. Approval from our institutional review board was obtained for the study. A written informed consent was obtained from each of the patients authorizing treatment, radiographic examination, and photographic documentation and publishing the above data in academic studies.
Detailed medical history and physical examination were acquired for each patient; neurological status was evaluated at each follow-up visit. Muscle power was examined and scored from 0 to 5 according to the Medical Research Council scale. Spinal cord function was evaluated using ASIA definitions. Muscle tone, reflexes, pinprick sensations, joint position, and vibration were tested, and the presence of bone deformity and soft-tissue tenderness or swelling was also recorded. Radiology including plain X-rays, CT, and MR was used to evaluate spinal features such as osteopenia, paravertebral abscess, disc space reduction, and endplate erosion, as well as gross vertebral and costovertebral bone destruction and deformities. In addition, the following lab tests were done for each patient in the first visit: complete blood count, erythrocyte sedimentation rate (ESR), liver function, and HIV serology. Liver function and ESR were monitored at each follow-up after the drug administration. Localized spinal deformity was measured as the angle between the upper and lower endplates of the collapsed vertebral levels using the Cobb method. Radiological evaluation was made before treatment and at each follow-up visit.
Chemotherapeutic agents were administered using a standard protocol. Patients were treated with a standard four-drug treatment that included rifampicin (15 mg/kg; maximum 600 mg/day), isoniazid (5 mg/kg; maximum 300 mg/day), pyrazinamide (25 mg/kg; maximum 2 g/day), and ethambutol (15–25 mg/kg; maximum 2 g/day)for 18 months .
Plain X-rays and MRI scans/CT scans and blood tests, as mentioned previously, were performed at 1, 3, 6, 9, 12, 18, 24, 30, and 42 months after starting the treatment to monitor response to treatment.
Patients who were ambulatory at the time of diagnosis were kept ambulatory during treatment, with restriction of heavy, load-bearing, contact activities. Patients who were bedridden at the time of diagnosis were kept in bed until clinical recovery (pain relief and neurological improvement) and then mobilized and ambulated with similar precautions as the ambulatory group, that is, with restrictions in heavy activity. Ambulation was permitted in these patients at an average of 3 to 4 weeks, and return to activities of daily living, light work, and noncontact activity was possible at 6 to 12 weeks, depending on the clinical response to treatment.
Information regarding treatment risks, such as death and morbidity, and the risks of chemotherapeutic management was provided to the patients. Patients were followed up at 1, 3, 6, 9, 12, 18, 24, 30, and 42 months after starting the therapy. Patients’ families were also given education about the importance of drug administration according to the protocol and adverse events related to the chemo agents .
This study was approved by the Institutional Review Board (IRB) of Southwest Hospital, Third Military Medical University. All procedures in the study were in accordance with the ethical standards of the IRB of Southwest Hospital and with the Helsinki Declaration.
The main symptoms, radiological data and lab results of patietns in the first visit
Symptoms at presentation
Low temp fever
42.35 ± 6.31
Numbers of involved vertebra
Disc space destruction
Vertebral body destruction
Affected spinal level
Pretreatment (ASIA D)
Posttreatment (ASIA D)
Pretreatment (ASIA E)
Posttreatment (ASIA E)
6.2 ± 3.11°
14.36 ± 6.31°
Mean VAS score
After beginning conservative medical management, 85 (95.4 %) of the 89 patients showed definite and persistent clinical response within 1 month, which was confirmed by radiological findings and blood tests. One year after the completion of treatment, the mean VAS score had improved from a pretreatment score of 7.6 to a posttreatment score of 1.7 (p < 0.001, paired sample t test), accompanied by complete resolution of pretreatment symptoms. Two years after the completion of treatment, the average VAS score was 0. Muscle strength was normal in 78 patients (91.76 %) with an ASIA grade of E, but hyperflaxia of tendon reflexes were present in some of these patients.
Four patients (4.5 %) did not respond to the four first-line drugs in the first month, and in the third month follow-up, they complained of severe back pain (average VAS 8.5); they also exhibited neurological deficits which were given an ASIA grade of D. The radiology showed significant progression of the vertebral destruction and paraverterbal abscess. Those patients were then treated with surgical correction, bone grafting, and chemotherapy with second-line drugs. Consequently, the outcomes of the four patients were not included in the following analysis.
Normal body temperature and ESR, negative sign of all pretreatment symptoms
No presence of sinus or abscess
Intact neurological function
Complete regression or calcification of lesion focus on CT/MRI scan
Primary-line four-drug anti-tuberculosis medications, used throughout the 18 months
More than four drugs used, for longer than 18 months
Progression of kyphosis over 10° at affected level at the end of treatment
Failure of nonoperative treatment, requiring surgical intervention
Excellent result: complete resolution of disease with first-line anti-tuberculosis treatment for 18 months, with no residues or side effects of treatment (criteria 1, 2, 3, 4, 5)
Good result: complete resolution of disease with first-line treatment for longer than 18 months, or with second-line drugs for 12 months or longer, with or without the occurrence of medically manageable side effects of drug therapy, such as gastrointestinal intolerance and drug-induced jaundice, necessitating frequent manipulations in their doses and regimen, but with eventual complete resolution (criteria 1, 2, 4, 6)
Fair result: complete resolution of disease, but with increased kyphosis of 10° or more at the affected level with no obvious or mild neurological compromising (criteria 1, 2, 3/4/5/6, 7)
Poor result: cases that did not respond to conservative treatment, primary or secondary line, and had to be eventually operated (criteria 8)
The outcomes of our series of 89 cases
Number of cases (total = 89)
The World Health Organization reports that China ranks second among the 22 countries with the highest burden of tuberculosis; spinal TB is the most common form of extrapulmonary tuberculosis and remains a severe public health threat in China .
The indication of conservative treatment for spinal TB is a continuing matter of debate. Historically, the chemotherapy was considered as the only effective way of treating spinal TB, until Hodgsonet al.  advocated progressive surgical intervention. Later on, to solve the debate upon the treatment choice, the British Medical Research Council (BMRC) have initiated a series of clinical trials since 1970, the trial included two branches, the Korea and Hongkong branches. In Korea, 350 patients of spinal TB were enrolled for the medical management, and in Hongkong, 150 patients all underwent surgery. Though the disease was more extensive in Korea, the great majority of patients in both countries achieved a favorable status at 15-year follow-up . Yet, on finishing the trial, they concluded that the surgical group had best results because these patients had more rapid abscess resolution and earlier and more frequent bone fusion . Obviously, the lack of universal inclusion criteria and sample balance of trial branches have weakened the credibility of this conclusion. Recently, Chandra et al. described their paradigms of management, in which they claimed that radical, instrumented surgeries should be offered in an early stage . Though the surgical intervention may have several advantages [3, 4, 12–14], it requires expertise, good anesthesia, and excellent perioperative care. It also requires hospitalization and is expensive and potentially dangerous. Complications can occur during the operation or postoperatively, which include reconstruction-related, vascular, neurological, visceral, and wound-related complications [3, 15–18]. Reconstruction failures can be breakage of the graft, screws, and rods, loss of correction, and failure of fusion . Vascular problems during surgery can be massive bleeding, hematoma formation, and thromboembolism. Neurological damage of surgery can be nerve root lesion, dura tears, spinal cord infarction, and plexus lesions. Visceral damage, especially ureteric lesions, can occur. Wound infections happen in 1 to 6 % of spinal surgeries .
Meanwhile, Tuli et al.  believed a combined method in treating the spinal TB and they advocated a “middle path” regimen, which included a less radical surgery along with chemotherapy, but they did not come up with a clear cut protocol to distinguish the surgical candidates from those who do not need surgeries.
As a result, several classifications were proposed for clinical decisions. Mehta and Bohjraj  proposed a system based on MRI appearance; however, they did not have a subtype for conservative treatment. Oguz et al.  came up with a classification based on the size and location of the lesion, in which they believed only patients with one level vertebral involvement, no neurological deficit, no collapse, and no abscess could be treated by drug therapy alone. Unfortunately, some recent studies have proved that patients with larger lesions and certain degrees of neurological deficit could be successfully treated with nonoperative methods. Nene and Bhojraj  showed in their study that 98 % in their series could be treated conservatively. Kotil et al.  did a prospective study on patients without major neurological deficits or severe spinal deformities (kyphotic angles smaller than 30°). Forty-two (95.4 %) of the 44 patients were successfully treated with conservative medical management and attained acceptable spinal deformity angles. In a prospective study, Ahmed Bakhsh  included 26 patients with spinal TB who were followed up for 12 months. Eighty-five percent of cases completely improved on medical treatment without any surgical intervention. Nene and Bhojraj  assessed the efficacy and results of nonsurgical treatment in thoracic spinal TB in adult patients in a retrospective analysis of 70 adults with thoracic spinal TB. Over 98 % of the patients (69 of 70) were successfully treated conservatively. Seventy-four percent had excellent to good results, with no mechanical residues of the disease.
To clarify the indications for conservative treatment, we characterized a subtype spinal TB, which were most likely to benefit from medical treatment. Furthermore, we have come up with an all-inclusive evaluation system to verify the efficacy of medical treatment alone.
In our study, we characterized a subtype spinal TB, which is the “mild spinal TB” in great detail and selected the study population accordingly. As shown in Table 1, the enrolled patients were all skeletal matured and had less than 30° kyphosis with mild to moderate neurological deficit. As to the location of lesion, the most commonly affected levels were lumbar segments (56.2 %); the least affected were sacral and cervical. This might have to do with the neurological status at presence; as in the lumbar region, the nerve roots are more tolerant to the spinal deformity or vertebral collapse, while the cervical segments are more sensitive and display worse neurological deficit. This was unlike the previous studies, in which thoracic or thoracic lumbar were the most commonly involved segments [6, 11, 19, 23–26]. Deformity or kyphosis is a significant problem in Pott’s disease. Kotil et al.  reported that the mean local spine deformity angle had increased from 11° (range 5°–19°) before medical treatment to 21° (range 10°–32°) after treatment. Nene and Bhojraj  found that the progression of local kyphosis ranged from 0° to 40° at the 2-year follow-up, though the initial thoracic kyphosis of all patients was less than 30°. In the BMRC trail , the authors found the progression between 8° and 16° at 36-month follow-up. In our results, however, after 18 months of standard chemotherapy, the mean local kyphosis had increased from 6.25 at first visit to 14.36 at 24-month follow-up, which was less than the progression in the literatures. Rajasekaran et al.  reported that the progress of deformity occurs in two distinct phases: phase I includes the changes in the active phase, and phase II includes changes after the disease is cured. The deformity progression is influenced by the severity of the angle before treatment, the level of the lesion, and the age of the patient. Therefore, the limited progression in our study could be explained by the following reasons: first, all the patients had a mild initial kyphosis and they were all skeletal mature. Furthermore, the long-term standard chemotherapy has been carried out effectively to ensure the elimination of the lesion. And last but not least, most involved vertebra were lumbar segments, which was unlike the previous literatures in which thoracic lumbar segments were most commonly involved [6, 11, 19, 23–26], this also indicated that patients with lumbar involvement tend to have less kyphotic progression. Different degrees of neurological improvements were reported in the literature [7, 24, 28–30]. Yet in our study, we did not see dramatic improvement of the neurological status for most patients at the end of 2-year follow-up. The reason could be because we only included patients with mild to moderate neurological deficit (ASIA D and E) and there were no patients with any intracanal abscess or spinal cord involvement. It is believed that the back pain could be caused by the compression of the paraverterbal abscess; therefore, the resolution of the perivertebral abscess could lead to significant pain relief [7, 12, 29, 30]. And most patients in our study have achieved significant pain relief after 12 months of chemotherapy and continued to get better at the end of the 24-month follow-up, though there was no significant difference between the results of 12 and 24 months.
Our study is not without limitations. Though most patients responded to the standard chemotherapy, four of them showed progression of the neurological deficit and back pain, which later were proved to be infected by drug-resistant mycobacterium. The failure of these cases emphasized the importance of drug susceptibility tests in the early stage of treatment. In our center, we have implemented DNA microarray for detection of isoniazid (INH) and rifampicin (RMP) resistance strains, which proved to be an accurate and rapid method . That is why all the failed cases were all before 2008, when we began to implement the DNA microarray as routine tests for spinal TB patients.
The mild spinal TB could be treated by standard chemotherapy alone. Surgery should be reserved for cases which do not respond well to chemotherapy. If the angle of spinal deformity and neurological deficits are within acceptable limits, medical management alone is sufficient enough.
We acknowledge the data collectors and the study participants from the Laboratory Department of Southwest Hospital. This study was partly funded by the Clinical Innovation Fund of Third Military Medical University (Grant No. SWH2011015).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO; WHOGtcG, 2015. http://www.who.int/tb/publications/global_report/en/.
- Jain AK. Tuberculosis of the spine: a fresh look at an old disease. J Bone Joint Surg. 2010;92(7):905–13.View ArticleGoogle Scholar
- Mak KC, Cheung KM. Surgical treatment of acute TB spondylitis: indications and outcomes. Eur Spine J. 2013;22 Suppl 4:603–11.View ArticlePubMedPubMed CentralGoogle Scholar
- Jutte PC, Van Loenhout-Rooyackers JH. Routine surgery in addition to chemotherapy for treating spinal tuberculosis. Cochrane Database Syst Rev. 2006;1:CD004532.PubMedGoogle Scholar
- Leone A, Guglielmi G, Cassar-Pullicino VN, Bonomo L. Lumbar intervertebral instability: a review. Radiology. 2007;245(1):62–77.View ArticlePubMedGoogle Scholar
- Bakhsh A. Medical management of spinal tuberculosis: an experience from Pakistan. Spine. 2010;35(16):E787–91.View ArticlePubMedGoogle Scholar
- Nene A, Bhojraj S. Results of nonsurgical treatment of thoracic spinal tuberculosis in adults. Spine J. 2005;5(1):79–84.View ArticlePubMedGoogle Scholar
- Hodgson ARSF, Fang HS, Ong GB. Anterior spinal fusion: the operative approach and pathological findings in 412 patients with Pott’s disease of the spine. Br J Surg. 1960;48:172–8.View ArticlePubMedGoogle Scholar
- A 15-year assessment of controlled trials of the management of tuberculosis of the spine in Korea and Hong Kong. Thirteenth Report of the Medical Research Council Working Party on Tuberculosis of the Spine. J Bone Joint Surg Br. 1998;80(3):456-62Google Scholar
- Cheung WY, Luk KD. Clinical and radiological outcomes after conservative treatment of TB spondylitis: is the 15 years’ follow-up in the MRC study long enough? Eur Spine J. 2013;22 Suppl 4:594–602.View ArticlePubMedPubMed CentralGoogle Scholar
- Chandra SP, Singh A, Goyal N, Laythalling RK, Singh M, Kale SS, et al. Analysis of changing paradigms of management in 179 patients with spinal tuberculosis over a 12-year period and proposal of a new management algorithm. World neurosurg. 2013;80(1-2):190–203.View ArticlePubMedGoogle Scholar
- Tuli SM. Historical aspects of Pott’s disease (spinal tuberculosis) management. Eur Spine J. 2013;22 Suppl 4:529–38.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang X, Ji J, Liu B. Management of spinal tuberculosis: a systematic review and meta-analysis. J Int Med Res. 2013;41(5):1395–407.View ArticlePubMedGoogle Scholar
- Jain AK, Dhammi IK. Tuberculosis of the spine: a review. Clin Orthop Relat Res. 2007;460:39–49.PubMedGoogle Scholar
- Cormican L, Hammal R, Messenger J, Milburn HJ. Current difficulties in the diagnosis and management of spinal tuberculosis. Postgrad Med J. 2006;82(963):46–51.View ArticlePubMedPubMed CentralGoogle Scholar
- Rasouli MR, Mirkoohi M, Vaccaro AR, Yarandi KK, Rahimi-Movaghar V. Spinal tuberculosis: diagnosis and management. Asian Spine J. 2012;6(4):294–308.View ArticlePubMedPubMed CentralGoogle Scholar
- Moon MS, Kim SS, Moon YW, Moon H, Kim SS. Surgery-related complications and sequelae in management of tuberculosis of spine. Asian Spine J. 2014;8(4):435–45.View ArticlePubMedPubMed CentralGoogle Scholar
- Moon MS. Tuberculosis of the spine. Controversies and a new challenge. Spine. 1997;22(15):1791–7.View ArticlePubMedGoogle Scholar
- Jutte PC, Castelein RM. Complications of pedicle screws in lumbar and lumbosacral fusions in 105 consecutive primary operations. Eur Spine J. 2002;11(6):594–8.View ArticlePubMedGoogle Scholar
- Tuli SM. Tuberculosis of the spine: a historical review. Clin Orthop Relat Res. 2007;460:29–38.PubMedGoogle Scholar
- Mehta JS, Bhojraj SY. Tuberculosis of the thoracic spine. A classification based on the selection of surgical strategies. J Bone Joint Surg. 2001;83(6):859–63.View ArticleGoogle Scholar
- Oguz E, Sehirlioglu A, Altinmakas M, Ozturk C, Komurcu M, Solakoglu C, et al. A new classification and guide for surgical treatment of spinal tuberculosis. Int Orthop. 2008;32(1):127–33.View ArticlePubMedPubMed CentralGoogle Scholar
- Kotil K, Alan MS, Bilge T. Medical management of Pott disease in the thoracic and lumbar spine: a prospective clinical study. J Neurosurg. 2007;6(3):222–8.Google Scholar
- Abbas A, Rizvi SR, Mahesri M, Salahuddin HR. Conservative management of spinal tuberculosis: initial series from Pakistan. Asian Spine J. 2013;7(2):73–80.View ArticlePubMedPubMed CentralGoogle Scholar
- Jain AK, Srivastava A, Saini NS, Dhammi IK, Sreenivasan R, Kumar S. Efficacy of extended DOTS category I chemotherapy in spinal tuberculosis based on MRI-based healed status. Indian J Orthop. 2012;46(6):633–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Li L, Zhang Z, Luo F, Xu J, Cheng P, Wu Z, et al. Management of drug-resistant spinal tuberculosis with a combination of surgery and individualised chemotherapy: a retrospective analysis of thirty-five patients. Int Orthop. 2012;36(2):277–83.View ArticlePubMedPubMed CentralGoogle Scholar
- Rajasekaran S, Prasad Shetty A, Dheenadhayalan J, Shashidhar Reddy J, Naresh-Babu J, Kishen T. Morphological changes during growth in healed childhood spinal tuberculosis: a 15-year prospective study of 61 children treated with ambulatory chemotherapy. J Pediatr Orthop. 2006;26(6):716–24.View ArticlePubMedGoogle Scholar
- Arora S, Sabat D, Maini L, Sural S, Kumar V, Gautam VK, et al. The results of nonoperative treatment of craniovertebral junction tuberculosis: a review of twenty-six cases. J Bone Joint Surg Am. 2011;93(6):540–7.View ArticlePubMedGoogle Scholar
- Njoku CH, Makusidi MA, Ezunu EO. Experiences in management of Pott’s paraplegia and paraparesis in medical wards of Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria. Ann Afr Med. 2007;6(1):22–5.View ArticlePubMedGoogle Scholar
- Park DW, Sohn JW, Kim EH, Cho DI, Lee JH, Kim KT, et al. Outcome and management of spinal tuberculosis according to the severity of disease: a retrospective study of 137 adult patients at Korean teaching hospitals. Spine. 2007;32(4):E130–5.View ArticlePubMedGoogle Scholar
- Zhang Z, Li L, Luo F, Cheng P, Wu F, Wu Z, et al. Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio DNA microarray: a prospective validation study. BMC Infect Dis. 2012;12:303.View ArticlePubMedPubMed CentralGoogle Scholar